{
    "title": "Arthritis drug shown to reduce risk of COVID death in large UK trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10573975/Arthritis-drug-shown-reduce-risk-COVID-death-large-UK-trial.html",
    "date": "2022-03-03",
    "keywords": [
        "baricitinib",
        "covid19",
        "trial",
        "treatment",
        "care",
        "recovery",
        "risk",
        "coronavirus",
        "oxford",
        "group",
        "combination",
        "march",
        "drug",
        "death",
        "regardless",
        "study",
        "addition",
        "random",
        "part",
        "university",
        "thursday",
        "corticosteroid",
        "dexamethasone",
        "tocilizumab",
        "result",
        "certainty",
        "response",
        "peter",
        "horby",
        "professor",
        "chief",
        "investigator",
        "research",
        "august",
        "world",
        "health",
        "organization",
        "panel",
        "year",
        "class",
        "janus",
        "kinase",
        "jak",
        "role",
        "immune",
        "system",
        "lead",
        "inflammation",
        "lung",
        "damage",
        "emergency",
        "use",
        "brand",
        "name",
        "remdesivir",
        "approval",
        "condition",
        "breakthrough",
        "pandemic",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}